ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Seagen Inc.
NEW YORK, March 13, 2023 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Seagen Inc. (NASDAQ: SGEN) and its board of directors concerning the proposed acquisition of the company by Pfizer Inc. (NYSE: PFE). Stockholders will receive $229.00 for each share of Seagen stock that they hold. The transaction is valued at approximately $43 billion and is expected to close in late 2023 or early 2024.
If you are a stockholder of Seagen Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/sgen/. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at [email protected], or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar outcome.
SOURCE Rowley Law PLLC
![](https://rt.prnewswire.com/rt.gif?NewsItemId=NY40909&Transmission_Id=202303131814PR_NEWS_USPR_____NY40909&DateId=20230313)
Share this article